...
首页> 外文期刊>Bone >Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network
【24h】

Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network

机译:用PET / CT和MRI参数将PET / CT和MRI参数与模型平均神经网络相结合来预测实验乳腺癌骨转移中的早期转移性疾病

获取原文
获取原文并翻译 | 示例
           

摘要

Macrometastases in bone are preceded by bone marrow invasion of disseminated tumor cells. This study combined functional imaging parameters from FDG-PET/CT and MRI in a rat model of breast cancer bone metastases to a Model-averaged Neural Network (avNNet) for the detection of early metastatic disease and prediction of future macrometastases. Metastases were induced in 28 rats by injecting MDA-MB-231 breast cancer cells into the right superficial epigastric artery, resulting in the growth of osseous metastases in the right hind leg of the animals. All animals received FDG-PET/CT and MRI at days 0, 10, 20 and 30 after tumor cell injection. In total, 18/28 rats presented with metastases at days 20 or 30 (64.3%). None of the animals featured morphologic bone lesions during imaging at day 10, and the imaging parameters acquired at day 10 did not differ significantly between animals with metastases at or after day 20 and those without (all p > 0.3). The avNNet trained with the imaging parameters acquired at day 10, however, achieved an accuracy of 85.7% (95% CI 67.3-96.0%) in predicting future macrometastatic disease (ROCAUC 0.90; 95% CI 0.76-1.00), and significantly outperformed the predictive capacities of all single parameters (all p <= 0.02). The integration of functional FDG-PET/CT and MRI parameters into an avNNet can thus be used to predict macrometastatic disease with high accuracy, and their combination might serve as a surrogate marker for bone marrow invasion as an early metastatic process that is commonly missed during conventional staging examinations.
机译:在骨中的宏观体酶前面是骨髓侵袭散发肿瘤细胞的侵袭。该研究将FDG-PET / CT和MRI中的功能性成像参数组合到乳腺癌骨转移的大鼠模型中,以检测早期转移性疾病和未来宏观运动酶预测的模型平均神经网络(AVNNET)。通过将MDA-MB-231乳腺癌细胞注入正确的表面上的脑内动脉,在28只大鼠中诱导转移,导致动物的右后腿中的骨转移生长。在肿瘤细胞注射后,所有动物在第0,10,20和30天接受FDG-PET / CT和MRI。共18/28只大鼠在20或30天(64.3%)时呈递转移。在第10天的成像期间没有任何动物在成像期间具有形态骨病变,并且在第10天在第20天或之后的动物之间获得的成像参数在20天或之后的动物之间没有显着差异(所有P> 0.3)。然而,在第10天获得的成像参数训练的AVNNET验证的成像参数的准确性为85.7%(95%CI 67.3-96.0%)预测未来的宏观疾病(Rocauc 0.90; 95%CI 0.76-1.00),并且显着优于所有单个参数的预测能力(所有P <= 0.02)。因此,功能性FDG-PET / CT和MRI参数的整合可用于预测高精度的宏观疾病,它们的组合可能用作骨髓侵袭的替代标记,作为常见的转移过程传统分期考试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号